A meeting of the Board of Directors of Lifeline Drugs & Pharma Ltd will be held on October 01, 2013, to consider the Split/Sub-division of face value of Equity Shares of the Company.
The Board will also consider proposal to alter Capital Clause of Memorandum of Association & Articles of Association to give effect of sub-division in face value of Equity Shares.
Shares of Lifeline Drugs & Pharma Ltd last traded in BSE at Rs.383, up by Rs.18 or 4.93%. The stock hit an intraday high of Rs.383 and low of Rs.383.
The total traded quantity was 2 compared to 2 week average of 1.